Australia markets open in 9 hours 1 minute

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.22+0.06 (+0.84%)
As of 10:59AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 457.64M
Enterprise value 823.71M
Trailing P/E N/A
Forward P/E 25.58
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.86
Price/book (mrq)2.67
Enterprise value/revenue 1.58
Enterprise value/EBITDA 12.12

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3117.27%
S&P500 52-week change 323.23%
52-week high 37.39
52-week low 32.82
50-day moving average 36.24
200-day moving average 34.95

Share statistics

Avg vol (3-month) 3502.21k
Avg vol (10-day) 3485.59k
Shares outstanding 563.83M
Implied shares outstanding 663.83M
Float 826.72M
% held by insiders 111.41%
% held by institutions 159.91%
Shares short (28 June 2024) 4624.62k
Short ratio (28 June 2024) 41.03
Short % of float (28 June 2024) 41.44%
Short % of shares outstanding (28 June 2024) 40.98%
Shares short (prior month 31 May 2024) 4591.33k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin -4.14%
Operating margin (ttm)4.34%

Management effectiveness

Return on assets (ttm)1.52%
Return on equity (ttm)-11.87%

Income statement

Revenue (ttm)522.74M
Revenue per share (ttm)8.30
Quarterly revenue growth (yoy)8.70%
Gross profit (ttm)N/A
EBITDA 42.62M
Net income avi to common (ttm)-21.65M
Diluted EPS (ttm)-0.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.17M
Total cash per share (mrq)0.39
Total debt (mrq)415.9M
Total debt/equity (mrq)191.28%
Current ratio (mrq)1.53
Book value per share (mrq)2.69

Cash flow statement

Operating cash flow (ttm)6.85M
Levered free cash flow (ttm)17.54M